Amyotrophic lateral sclerosis (ALS)

New Faculty Spotlight: Sali Farhan

23 Feb 2021

Sali Farhan is an accomplished human genomicist who bridges the gap between the clinic and the lab.

A brighter future for ALS patients

1 May 2020

The first drug to be given Health Canada approval for amyotrophic lateral sclerosis (ALS) in more than two decades is now covered by Quebec public health insurance, a major victory for ALS patients...

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

 

The Neuro is a McGill research and teaching institute; delivering high quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

FacebookinstagramtwitterlinkedInyoutube

Back to top